BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19505873)

  • 1. Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.
    Ku WC; Chiu SK; Chen YJ; Huang HH; Wu WG; Chen YJ
    Mol Cell Proteomics; 2009 Sep; 8(9):2034-50. PubMed ID: 19505873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of hepatocyte nuclear factor 4alpha tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity.
    Maeda Y; Seidel SD; Wei G; Liu X; Sladek FM
    Mol Endocrinol; 2002 Feb; 16(2):402-10. PubMed ID: 11818510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation.
    Gong XQ; Li L
    J Biol Chem; 2002 Apr; 277(14):12310-7. PubMed ID: 11809751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.
    Deltour S; Guerardel C; Leprince D
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14831-6. PubMed ID: 10611298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M; Darley M; Primrose JN; Blaydes JP
    Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
    Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
    Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.
    Amann JM; Nip J; Strom DK; Lutterbach B; Harada H; Lenny N; Downing JR; Meyers S; Hiebert SW
    Mol Cell Biol; 2001 Oct; 21(19):6470-83. PubMed ID: 11533236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases.
    Saleh M; Rambaldi I; Yang XJ; Featherstone MS
    Mol Cell Biol; 2000 Nov; 20(22):8623-33. PubMed ID: 11046157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.
    Murphy M; Ahn J; Walker KK; Hoffman WH; Evans RM; Levine AJ; George DL
    Genes Dev; 1999 Oct; 13(19):2490-501. PubMed ID: 10521394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B.
    Yang L; Mei Q; Zielinska-Kwiatkowska A; Matsui Y; Blackburn ML; Benedetti D; Krumm AA; Taborsky GJ; Chansky HA
    Biochem J; 2003 Feb; 369(Pt 3):651-7. PubMed ID: 12398767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression.
    Senawong T; Peterson VJ; Avram D; Shepherd DM; Frye RA; Minucci S; Leid M
    J Biol Chem; 2003 Oct; 278(44):43041-50. PubMed ID: 12930829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZBTB2, a novel master regulator of the p53 pathway.
    Jeon BN; Choi WI; Yu MY; Yoon AR; Kim MH; Yun CO; Hur MW
    J Biol Chem; 2009 Jul; 284(27):17935-46. PubMed ID: 19380588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mad proteins contain a dominant transcription repression domain.
    Ayer DE; Laherty CD; Lawrence QA; Armstrong AP; Eisenman RN
    Mol Cell Biol; 1996 Oct; 16(10):5772-81. PubMed ID: 8816491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity of mammalian transcriptional repressors.
    Thiel G; Lietz M; Bach K; Guethlein L; Cibelli G
    Biol Chem; 2001 Jun; 382(6):891-902. PubMed ID: 11501753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein.
    Xia ZB; Anderson M; Diaz MO; Zeleznik-Le NJ
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8342-7. PubMed ID: 12829790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of the SWI/SNF protein Brg1 by a multiprotein complex effects transcriptional repression in murine erythroid progenitors.
    Xu Z; Meng X; Cai Y; Koury MJ; Brandt SJ
    Biochem J; 2006 Oct; 399(2):297-304. PubMed ID: 16800816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2.
    Yu F; Thiesen J; Strätling WH
    Nucleic Acids Res; 2000 May; 28(10):2201-6. PubMed ID: 10773092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment.
    Jee YK; Gilmour J; Kelly A; Bowen H; Richards D; Soh C; Smith P; Hawrylowicz C; Cousins D; Lee T; Lavender P
    J Biol Chem; 2005 Jun; 280(24):23243-50. PubMed ID: 15826950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression by TTK69 of GAGA-mediated activation occurs in the absence of TTK69 binding to DNA and solely requires the contribution of the POZ/BTB domain of TTK69.
    Pagans S; Piñeyro D; Kosoy A; Bernués J; Azorín F
    J Biol Chem; 2004 Mar; 279(11):9725-32. PubMed ID: 14701830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity.
    Phillips A; Teunisse A; Lam S; Lodder K; Darley M; Emaduddin M; Wolf A; Richter J; de Lange J; Verlaan-de Vries M; Lenos K; Böhnke A; Bartel F; Blaydes JP; Jochemsen AG
    J Biol Chem; 2010 Sep; 285(38):29111-27. PubMed ID: 20659896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.